This information was originally presented on September 20, 2014, at the NCCN 9th Annual Congress: Hematologic Malignancies™ held in New York, New York.

The treatment of older or medically frail patients with chronic lymphocytic leukemia (CLL) presents unique challenges to clinicians attempting to maximize efficacy while avoiding significant toxicity.

A live, interactive, CME-certified Grand Rounds series presented by leading experts in the treatment of chronic lymphocytic leukemia.

A live, interactive, CME-certified Grand Rounds series presented by leading experts in the treatment of chronic lymphocytic leukemia.

A live, interactive, CME-certified Grand Rounds series presented by leading experts in the treatment of chronic lymphocytic leukemia.

A live, interactive, CME-certified Grand Rounds series presented by leading experts in the treatment of chronic lymphocytic leukemia.

A live, interactive, CME-certified Grand Rounds series presented by leading experts in the treatment of chronic lymphocytic leukemia.

A live, interactive, CME-certified Grand Rounds series presented by leading experts in the treatment of chronic lymphocytic leukemia.

A live, interactive, CME-certified Grand Rounds series presented by leading experts in the treatment of chronic lymphocytic leukemia.

A live, interactive, CME-certified Grand Rounds series presented by leading experts in the treatment of chronic lymphocytic leukemia.